by smcork | Oct 11, 2012 | Commentary |
When the Supreme Court upheld the constitutionality of the Patient Protection and Affordable Care Act on June 28, the impact was diverse and widespread. Relief was felt in one corner of the pharmaceutical industry, however, as the decision protected continued...
